FCGR2B and systemic lupus erythematosus: We found that IRF5 was critical for disease development in the FcγRIIB−/−Yaa and FcγRIIB−/− lupus models as IRF5-deficient FcγRIIB−/−Yaa and FcγRIIB−/− mice developed minimal disease manifestations [21].